Form 4: ARGAN CEO Sells Shares, Gifts to Foundation
Insider Transaction Report
ARGAN Inc.'s President and CEO, David Hibbert Watson, reported open market sales of common stock and a gift to a donor-advised fund.
Summary
- David Hibbert Watson, President and CEO of ARGAN Inc. and a Director, reported transactions involving the company's common stock.
- On October 9, 2025, Mr. Watson sold 4,441 shares of ARGAN common stock on the open market at an average price of $277.01 per share.
- On the same date, he gifted 559 shares of ARGAN common stock to The David and Laura Watson Foundation, a donor-advised fund.
- Subsequently, The David and Laura Watson Foundation sold these 559 shares on the open market at a price of $272.27 per share.
- All reported transactions were made pursuant to a Rule 10b5-1(c) plan.
- Following these transactions, Mr. Watson directly beneficially owns 47,132 shares of ARGAN common stock, and his indirect beneficial ownership through the foundation is now 0 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale reduces ownership, the transactions were conducted under a pre-arranged 10b5-1 plan, indicating personal financial planning rather than a reaction to new company-specific information. The gift to a foundation is philanthropic.
Negatives
- The transactions represent a reduction in the direct and indirect beneficial ownership of ARGAN common stock by the President and CEO.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
This Form 4 filing details routine insider transactions and does not provide information related to broader industry trends or competitive landscape.
Related Party Transactions
- David Hibbert Watson gifted 559 shares of ARGAN common stock to The David and Laura Watson Foundation, a donor-advised fund.
Stakeholder Impact
- Shareholders may note a slight reduction in the CEO's beneficial ownership, though the transactions were pre-planned under a Rule 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 10/09/2025 | Date of reported stock transactions (sale and gift) |
| 10/10/2025 | Date the Form 4 was signed and filed |
Recommendation
holdThe Form 4 filing reports routine insider transactions, specifically sales and a gift under a Rule 10b5-1 plan. These types of transactions are generally for personal financial management and do not typically signal a change in the company's fundamental outlook or warrant a strong buy or sell recommendation based solely on this information. Investors should consider broader company performance and market conditions.
Keywords
ARGAN, AGX, Insider Trading, Form 4, Stock Sale, CEO, Director, David Watson, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.